Eli Lilly and Co (NYSE:LLY)
| 325.64 Delayed Data As of Jun 24 |  +0.02 / +0.01%Today’s Change | 220.20 Today|||52-Week Range 325.82 | +17.89% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | 1.1B | 1.1B | 4.2B | 1.3B | |
| Depreciation | 415.5M | 345.5M | 356.5M | 247.4M | ||
| Total Other Cash Flow | 236.1M | 553.5M | -3.5B | 217.9M | ||
| Funds From Operations | 1.8B | 2.2B | 1.0B | 1.9B | ||
| Funds From/For Other Operating Expenses | -293.9M | 740.5M | 714.3M | 802.1M | ||
| Net Cash Flow - Operating Activities | 2.1B | 1.4B | 311.3M | 1.1B | ||
| Investing | Increase In Investments | -43.2M | -118.2M | -94.3M | -86.4M | |
| Decrease In Investments | 88.4M | 81.8M | 119.5M | 386.3M | ||
| Capital Expenditures | -269.8M | -394.3M | -203.7M | -240.3M | ||
| Fixed Asset Disposal | -- | 3.6M | -- | -- | ||
| Net Assets From Acquisitions | 0.00 | 0.00 | -6.9B | 0.00 | ||
| Other Investing - Uses | -143.5M | -2.5M | -385.6M | 46.4M | ||
| Net Cash Flow Investing | -398.1M | -659.0M | -7.7B | 61.0M | ||
| Financing | Short Term Borrowings | -2.0B | 99.2M | 1.9B | -286.1M | |
| Long Term Borrowings | 2.5B | 0.00 | 4.4B | 0.00 | ||
| Long Term Debt Reduction | 0.00 | -7.6M | -600.0M | -200.0K | ||
| Net Proceeds Stock Sale | 0.00 | 1.7B | 0.00 | 0.00 | ||
| Common Preferred Redeemed | -1.0B | -1.1B | -3.5B | 0.00 | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -572.6M | -572.6M | -637.2M | -598.0M | ||
| Other Sources - Financing | 1.7B | -1.7B | 0.00 | 0.00 | ||
| Other Uses - Financing | 83.7M | 58.7M | 193.7M | 1.5M | ||
| Net Cash Flow - Financing | 432.7M | -1.6B | 1.4B | -885.8M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -13.7M | -111.8M | 37.8M | 27.1M | |
| Net Change In Cash | 2.2B | -850.0M | -6.0B | 226.7M | ||
